Exagen Inc. (XGN) Tops Q4 EPS by 12c

Exagen Inc. (NASDAQ: XGN) reported Q4 EPS of ($0.20), $0.12 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $13.66 million versus the consensus estimate of $14.17 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• Capri stock surges on potential buyer interest report
• Increasing unusual option volume: XNDU DAR CPRI EXE APH GRAB CMPX AMLP DNA BORR
• Fed’s Jefferson says discount window upgrades aid stability